Treatment of palmoplantar warts with a diphencyprone and salicylic acid ointment

Australasian Journal of Dermatology

Volumn 47, Issue 3, 2006, Pages 182-185

  Armour, Katherine ^a   Orchard, David ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Contact hypersensitivity; Topical immunotherapy; Viral wart

Indexed keywords

DIPHENCYPRONE; SALICYLIC ACID;

APPLICATION SITE REACTION; ARTICLE; FOLLOW UP; HUMAN; KERATOSIS PALMOPLANTARIS; QUESTIONNAIRE; SENSITIVITY ANALYSIS; VERRUCA PLANTARIS;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYCLOPROPANES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FOLLOW-UP STUDIES; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; KERATOLYTIC AGENTS; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; SALICYLIC ACID; TREATMENT OUTCOME; WARTS;

EID: 33745759482     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2006.00268.x     Document Type: Article

References (18)

1. Jablonska S. Traditional therapies for treatment of condylomata acuminata (genital warts). Australas. J. Dermatol. 1998; 39: S2-4.
2. Torrelo A. What's new in the treatment of viral warts in children. Pediatr. Dermatol. 2002; 19: 191-9.
3. Higgins E, Du Vivier A. Topical immunotherapy: unapproved uses, dosages, or indications. Clin. Dermatol. 2002; 20: 515-21.
4. Buckley DA, Du Vivier AWP. The therapeutic use of topical contact sensitizers in benign dermatoses. Br. J. Dermatol. 2001; 145: 385-405.
5. Greenberg JH, Smith TL, Katz RM. Verrucae vulgaris rejection. A preliminary study of contact dermatitis and cellular immunity response. Arch. Dermatol. 1973; 107: 580-2.
6. Wilkerson MG, Henkin J, Wilkin JK. Diphenylcyclopropenone: examination for potential contaminants, mechanisms of sensitization and photochemical stability. J. Am. Acad. Dermatol. 1984; 11: 802-7.
7. Naylor MF, Neldner KH, Yarbrough GK, Rosio TJ, Iriondo M, Yeary J. Contact immunotherapy of resistant warts. J. Am. Acad. Dermatol. 1988; 19: 679-839.
8. Buckley DA, Keane FM, Munn SE, Fuller LC, Higgins EM, Du Vivier AWP. Recalcitrant viral warts treated by diphencyprone immunotherapy. Br. J. Dermatol. 1999; 141: 292-6.
9. Rampen FHJ, Steijlen PM. Diphencyprone in the management of refractory palmoplantar and periungual warts: an open study. Dermatology 1996; 193: 236-8.
10. Steele K, Shirodaria P, O'Hare M, Merrett JD, Irwin WG, Simpson DI, Pfister H. Monochloroacetic acid and 60% salicylic acid as a treatment for simple plantar warts: effectiveness and mode of action. Br. J. Dermatol. 1988; 118: 537-43.
11. Gibbs S, Harvey I, Sterling JC, Stark R. Local treatments for cutaneous warts. Cochrane Database Syst. Rev. 2005; 3: CD001781.
12. Micali G, Dall'Oglio F, Nasca MR, Tedeschi A. Management of cutaneous warts. An evidence-based approach. Am. J. Clin. Dermatol. 2004; 5: 311-17.
13. Upitis JA, Krol A. The use of diphenylcyclopropenone in the treatment of recalcitrant warts. J. Cutan. Med. Surg. 2002; 6: 214-17.
14. Lane PR, Hogan DJ. Diphencyprone (Letter). J. Am. Acad. Dermatol. 1988; 19: 364-5.
15. Puig L, Alegre M. Erythema multiforme-like reaction following diphencyprone treatment of plane warts. Int. J. Dermatol. 1994; 33: 201-3.
16. Short KA, Higgins EM. Urticaria as a side-effect of diphencyprone therapy for resistant viral warts (Letter). Br. J. Dermatol. 2005; 152: 583-4.
17. Massing AM, Epstein WL. Natural history of warts. A two-year study. Arch. Dermatol. 1963; 87: 306-10.
18. Ciconte A, Campbell J, Tabrizi S, Garland S, Marks R. Warts are not merely blemishes on the skin: a study on the morbidity associated with having viral cutaneous warts. Australas. J. Dermatol. 2003; 44: 169-73.